Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κ.

Clinical lymphoma, myeloma & leukemia - 1 Nov 2020

Narita Kentaro, Kobayashi Hiroki, Suzuki Tomo, Ichikawa Daisuke, Yamazaki Kazuto, Terawaki Hiroyuki, Suehara Yasuhito, Miura Daisuke, Takeuchi Masami, Matsue Kosei

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunoglobulin G
Share to Lymphoma, B-Cell
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Myeloid Differentiation Factor 88

Source

Identifiers

PMID: 32660905
DOI: 10.1016/j.clml.2020.06.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κ.PMID 32660905Read ↗

MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.Semantic proximity Read ↗

MYD88 gene and protein: molecular architecture, signalling mechanisms and clinical implications in lymphoid malignancies.Semantic proximity Read ↗

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.Semantic proximity Read ↗

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?Semantic proximity Read ↗

Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.Semantic proximity Read ↗

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells.Semantic proximity Read ↗

[MyD88 L265P mutation and B cell tumor].Semantic proximity Read ↗

MYD88 L265P Somatic MutationSemantic proximity Read ↗

B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.Semantic proximity Read ↗

Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.Semantic proximity Read ↗

Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.